Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is a pre-filled, once-weekly injection pen containing semaglutide, made by Novo Nordisk. Each pen is single-use, comes in a range of colour-coded strengths, and is dispensed in a small cardboard outer carton. If you've been searching for wegovy images to understand what arrives through the post or what the injection process involves, the honest answer is straightforward: it looks much like any other modern auto-injector. Wegovy is a semaglutide medicine, and like all prescription-only weight-loss injections it can only be dispensed following a clinical assessment by a qualified prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for images of Wegovy are doing so because they're nervous. That's completely understandable, the idea of injecting yourself at home, week after week, trips a lot of people up before they've even filled a prescription. The misconception is that GLP-1 pens resemble the large, clinical syringes you might associate with a hospital ward. They don't. Wegovy uses a compact auto-injector roughly the size of a thick marker pen. You press the cap end against your skin, press the button, and the needle (which is very short and fine) does its work without you seeing it at all. The injection itself takes only a few seconds.
Novo Nordisk designed the device so that the needle is hidden inside the tip both before and after use. There's an audible click when the dose starts and a second when it's complete. Many people are surprised by how undramatic the process is. If you've ever watched someone use an EpiPen, the mechanism is conceptually similar, though the pens are smaller and the force is gentler. For a closer look at how the appearance of the face and body can change over a course of treatment, our page on Wegovy face images covers what the clinical evidence says about visible changes.
When Wegovy is dispensed by a GPhC-registered pharmacy like ours, it arrives in a plain outer box, nothing on the outside identifies it as a weight-loss medicine. Inside, you'll find the cardboard carton from the manufacturer, which contains the pre-filled pen, a capped needle tip already attached, and the Patient Information Leaflet. The pens are colour-banded: each strength has its own distinct colour on the label and the dial area, which matters because the dose titration schedule moves through several steps across many months. The stages of Wegovy involve gradually increasing the dose; having that colour-coding is a simple visual check that you're using the right pen at the right stage.
The pen body itself is white or off-white plastic, with a small window that lets you confirm the liquid inside is clear and colourless before you inject. If it's cloudy, discoloured, or contains particles, the leaflet advises you not to use it and to contact your pharmacy. Storage is in the refrigerator between 2°C and 8°C, think of it as living in the fridge door, much like an insulin pen. If you're looking at the cost of the treatment alongside what you're receiving physically, our Wegovy cost page breaks down what a private prescription typically includes.
In April 2026 the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, the first at that strength to be dispensed as one weekly injection rather than three 2.4 mg pens. According to the government's announcement of the single-dose 7.2 mg pen approval, the new device has an auto-dosing mechanism, a built-in covered needle, and locks automatically after use. It is approved only for adults with a BMI of 30 or above and cannot be used for the cardiovascular indication. Visually it is slightly different from the lower-dose pens, the lock-after-use mechanism means the tip is non-retractable once fired, which is relevant for safe disposal. Always use an appropriate sharps container rather than a household bin.
The 7.2 mg dose is the maximum in the Wegovy titration schedule. Patients don't begin there, the starting dose remains 0.25 mg, moving upward in steps under prescriber supervision. If you're curious about how that progression works in practice, the Wegovy dose stages page covers the schedule in detail. Whether you'd ever reach 7.2 mg, and in which pen format, is something a prescriber would confirm at review. It's worth knowing the option exists, but the right stage for you depends entirely on clinical judgment.
One reason people search specifically for Wegovy images is that the pictures circulating on social media and forums are often photos of counterfeit pens, stock imagery of unrelated syringes, or pictures of Ozempic (a different semaglutide product licensed for type 2 diabetes, not weight loss, the two are commonly confused). The MHRA has warned publicly about fake weight-loss pens sold without a valid prescription, and counterfeit products can look almost identical to genuine ones at a glance. The safest way to know exactly what a genuine Wegovy pen looks like is to receive one dispensed by a pharmacy you can verify on the GPhC pharmacy register. If you're considering treatment and want to understand the full picture first (including the disadvantages of Wegovy that don't always make it into promotional material) a free consultation is the right place to start. Our prescribers answer these questions every day, before 12pm if you want your prescription reviewed the same afternoon.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.